Literature DB >> 12653913

A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.

Ivan Semenovitch1, Omar Lupi.   

Abstract

BACKGROUND: Varicella-zoster virus (VZV) is an alpha-herpesvirus causing varicella (chickenpox) and herpes zoster (shingles). Varicella results from primary VZV infection, and is a common childhood illness associated with fever and a generalized, pruritic, vesicular eruption. Herpes zoster is caused by VZV reactivation later in life (most cases after the fifth decade), and is characterized by a localized, painful, and vesicular eruption involving one or adjacent dermatomes. The incidence of herpes zoster increases with age and immunosuppression.
OBJECTIVE: To estimate the seroprevalence of VZV in the Brazilian pediatric population by evaluating the prevalence of specific antibodies to VZV in children from two university hospitals in the state of Rio de Janeiro.
METHODS: A population composed of 160 children derived from two university hospitals in the state of Rio de Janeiro was included in the study. All patients completed a questionnaire regarding their socio-epidemiologic characteristics, and a complete physical examination was performed. All blood samples were screened using a commercial enzyme-linked fluorescent assay (ELFA) kit, specific for the detection of immunoglobulin G (IgG) antibodies to VZV.
RESULTS: The seroprevalence of VZV was 58.1% in the overall population, with a statistically significant correlation between seroprevalence and increasing age (P < 0.0001). A previous history of measles infection (P < 0.04), previous history of varicella infection (P < 0.0001), and the presence of skin lesions (P < 0.05) were significantly associated with seropositivity to VZV.
CONCLUSIONS: Further studies should be performed in order to evaluate the endemicity of VZV infections and to establish criteria for the use of the specific vaccine in Brazil.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653913     DOI: 10.1046/j.1365-4362.2003.01310.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.

Authors:  Yasaman Vojgani; Saeed Zarei; Samira Rajaei; Leili Chamani-Tabriz; Fatemeh Ghaemimanesh; Nematallah Mohammadinia; Mahmood Jeddi-Tehrani
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

2.  Exposure rate of VZV among women attending antenatal care clinic in Sri Lanka - a cross sectional study.

Authors:  Saluwadana Walawwe Pavithra Lakmini Daulagala; Faseeha Noordeen; Mohamed Mukthar Fathina Fara; Chathura Rathnayake; Kapila Gunawardana
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090

3.  Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review.

Authors:  Luiza Helena Falleiros Arlant; Maria Catalina Pirez Garcia; Maria L Avila Aguero; Miguel Cashat; Cintia Irene Parellada; Lara J Wolfson
Journal:  BMC Public Health       Date:  2019-05-08       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.